mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.087 |
0.1 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.1 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.1 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.1 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.049 |
0.1 |